"

Module 9

This module contains required readings from:

  • Pharmacology for Nurses– 28, 27

Please read and review the following pages to prepare for Module 9. Additional readings are available in WyoCourses.

Learning Objectives

By the end of this module, you will be able to:

  • MO 9.1 Differentiate between the pathophysiological mechanisms of Type 1 and Type 2 diabetes mellitus and analyze the rationale for insulin therapy during hospitalization. (CO1 & 5)
  • MO 9.2 Demonstrate safe calculation and administration of insulin therapies using knowledge of pharmacokinetics (onset, peak, duration) for rapid-acting and intermediate-acting insulin formulations. (CO2, 3, & 4)
  • MO 9.3 Interpret laboratory values (A1C, serum creatinine, blood glucose) to assess glycemic control, identify complications risk, and determine medication safety considerations. (CO1 & 4)
  • MO 9.4 Recognize signs and symptoms of hypoglycemia, implement evidence-based emergency management protocols, and analyze causative factors using insulin timing and patient assessment data. (CO1, 3, & 4)
  • MO 9.5 Assess medication safety considerations related to renal function and determine appropriate interventions for patients with compromised kidney function taking antidiabetic medications. (CO2, 3, & 4)
  • MO 9.6 Develop comprehensive, evidence-based patient education plans for insulin therapy including injection technique, storage, monitoring, and self-management principles. (CO3 & 6)
  • MO 9.7 Synthesize pathophysiology, pharmacology, and clinical assessment data to provide safe, patient-centered diabetes care and communicate effectively with the healthcare team. (CO3, 4, & 5)

Next- 9.1 Diabetic Drugs

License

Icon for the Creative Commons Attribution 4.0 International License

Foundational Patho-Pharmacology for Nurses Copyright © 2025 by University of Wyoming Fay W. Whitney School of Nursing is licensed under a Creative Commons Attribution 4.0 International License, except where otherwise noted.